Search

Your search keyword '"Hideaki Matsui"' showing total 125 results

Search Constraints

Start Over You searched for: Author "Hideaki Matsui" Remove constraint Author: "Hideaki Matsui"
125 results on '"Hideaki Matsui"'

Search Results

52. Auditory event-related potentials in Parkinson's disease: Prominent correlation with attention

53. Thalamic Hyperperfusion in Verbal Hallucination of Parkinsonian Patients

54. Depression in Parkinson’s disease

55. Wisconsin Card Sorting Test and brain perfusion imaging in Parkinson's disease

56. Disruptions of the fornix fiber in parkinsonian patients with excessive daytime sleepiness

57. Impaired Visual Acuity as a Risk Factor for Visual Hallucinations in Parkinson’s Disease

58. Identification of the zebrafish red nucleus using Wheat Germ Agglutinin transneuronal tracing

59. Zebrafish jam-b2 Gal4-enhancer trap line recapitulates endogenous jam-b2 expression in extraocular muscles

60. Three-dimensional stereotactic surface projection study of orthostatic hypotension and brain perfusion image in Parkinson's disease

61. Metaiodobenzylguanidine (MIBG) uptake in Parkinson’s disease also decreases at thyroid

62. The Relation Between Visual Hallucinations and Visual Evoked Potential in Parkinson Disease

63. N-isopropyl-p-123I Iodoamphetamine Single Photon Emission Computed Tomography Study of Parkinson's Disease with Dementia

64. Structures and Mixed-valence State in Ni(mnt) 2 Salts of Biferrocenes

65. An optimized method for counting dopaminergic neurons in zebrafish

66. Functional regionalization of the teleost cerebellum analyzed in vivo

67. Development of transaxle for hybrid vehicle

68. A Case of Laryngeal Web Diagnosed after Induction of Anesthesia

69. Multiple Sclerosis Following Splenectomy as a Treatment for Idiopathic Thrombocytopenic Purpura

70. PINK1 and Parkin complementarily protect dopaminergic neurons in vertebrates

71. ATP13A2 deficiency induces a decrease in cathepsin D activity, fingerprint-like inclusion body formation, and selective degeneration of dopaminergic neurons

72. TigarB causes mitochondrial dysfunction and neuronal loss in PINK1 deficiency

73. Uniaxial Strain Effects on Superconducting Transition in Y0.98Ca0.02Ba2Cu4O8

74. [An investigation on prognostic diagnosis and therapeutic effects for peripheral facial nerve palsy]

75. Study of Magnetic Domain Dynamics Using Nonlinear Magnetic Responses: Magnetic Diagnostics of the Itinerant Magnet MnP

76. Ammonium chloride and tunicamycin are novel toxins for dopaminergic neurons and induce Parkinson's disease-like phenotypes in medaka fish

77. Proteasome inhibition in medaka brain induces the features of Parkinson's disease

79. A chemical neurotoxin, MPTP induces Parkinson's disease like phenotype, movement disorders and persistent loss of dopamine neurons in medaka fish

80. [Pathological mechanisms of Parkinson's disease]

81. Dementia in Parkinson's disease: diffusion tensor imaging

82. Wisconsin Card Sorting Test in Parkinson's disease: diffusion tensor imaging

83. Trousseau syndrome due to pleural mesothelioma

84. Viable Neuronopathic Gaucher Disease Model in Medaka (Oryzias latipes) Displays Axonal Accumulation of Alpha-Synuclein

85. Hypoperfusion of the auditory and prefrontal cortices in Parkinsonian patients with verbal hallucinations

86. Excessive daytime sleepiness in Parkinson disease: a SPECT study

87. Heterogeneous factors in dementia with Parkinson's disease: IMP-SPECT study

88. Minor depression and brain perfusion images in Parkinson's disease

89. Encephalopathy and severe neuropathy due to probable systemic vasculitis as an initial manifestation of mixed connective tissue disease

90. HTLV-I-associated peripheral neuropathy with smoldering-type adult T-cell leukemia

91. Frontal assessment battery and brain perfusion image in Parkinson's disease

92. Extraction Method for Design Principle of Static Behavior of Vehicle Suspension System

93. Biferrocene-M(mnt)2 charge-transfer complexes (M = Ni, Co; mnt = maleonitriledithiolate). structure, valence states, and magnetic properties

94. Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms?

95. Three-dimensional stereotactic surface projection study of freezing of gait and brain perfusion image in Parkinson's disease

96. Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy

97. Brain perfusion differences between Parkinson's disease and multiple system atrophy with predominant parkinsonian features

98. [Two cases of Parkinson's disease in which visual hallucinations disappeared after cataract surgery]

Catalog

Books, media, physical & digital resources